LEE'S PHARM News

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 2 04:03 ET

LEE'S PHARM: Notification Letter to Non-registered Shareholders and Reply Form

Apr 19 06:33 ET

LEE'S PHARM: Notification Letter to Registered Shareholders and Reply Form

Apr 19 06:28 ET

LEE'S PHARM: Proxy Form

Apr 19 06:18 ET

LEE'S PHARM: Environmental, Social and Governance Report 2023

Apr 19 06:01 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 2 03:19 ET

LEE'S PHARM: Final Dividend for the Year Ended 31 December 2023

Mar 26 04:58 ET

LEE'S PHARM: Letter to Non-registered Shareholders - Arrangement for Electronic Dissemination of Corporate Communications and Reply Form

Mar 13 05:13 ET

LEE'S PHARM: Letter to Registered Shareholders - Arrangement for Electronic Dissemination of Corporate Communications and Reply Form

Mar 13 05:10 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 1 04:52 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 1 04:51 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 3 05:06 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 1, 2023 00:21 ET

LEE'S PHARM: Voluntary Announcement - Adasuve Obtains Drug Registration Certificate

Nov 28, 2023 09:23 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

Nov 1, 2023 05:40 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023

Oct 3, 2023 05:56 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023

Sep 4, 2023 06:01 ET

LEE'S PHARM: Interim Dividend for the Six Months Ended 30 June 2023

Aug 30, 2023 04:56 ET

LEE'S PHARM: Voluntary Announcement - Update on an Investigational Anesthesia Product

Aug 21, 2023 09:59 ET

LEE'S PHARM: Voluntary Announcement - Apremilast Tablet Obtains Drug Registration Certificate

Aug 21, 2023 09:54 ET